Form 4 Filing for Arcturus Therapeutics Holdings Inc. - Markels John

This Form 4 filing details a stock option grant to Markels John, a director at Arcturus Therapeutics Holdings Inc. (ARCT). On June 5, 2026, John received 15,000 stock options with a purchase price of $0.00, which are exercisable immediately. These options are part of his 2026 annual grant as a board member and vest monthly over one year. The underlying security is Common Stock. The filing also indicates that the options have an expiration date of June 5, 2036, and the conversion or exercise price is $7.30. The post-transaction shares owned by Markels John are 15,000. The filing was signed on June 15, 2026, by Ilan Katz, attorney-in-fact.